3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
5
Ovarian Neoplasms
3
Colorectal Neoplasms
3
Thyroid Neoplasms
2
Pancreatic Neoplasms
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Lymphoma
2
Hematologic Neoplasms
2
Glioma
2
Endometrial Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Neurofibromatosis 1
1
Lymphatic Metastasis
1
Lung Neoplasms
1
Klatskin Tumor
1
Hereditary Sensory and Autonomic Neuropathies
1
Gallbladder Neoplasms
1
Fallopian Tube Neoplasms
1
Esophageal Neoplasms
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Renal Cell
1
Interventions
Carboplatin
5
Radiotherapy
4
Radiation
3
Radiotherapy, Conformal
2
Platinum
2
Pemetrexed
2
Paclitaxel
2
Magnetic Resonance Spectroscopy
2
Immunoglobulin G
2
Disulfides
2
Cisplatin
2
Bevacizumab
2
1,2-diaminocyclohexaneplatinum II citrate
2
veliparib
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
methoxyamine
1
lazertinib
1
durvalumab
1
capmatinib
1
Taxes
1
Specimen Handling
1
Radiotherapy, Intensity-Modulated
1
Nivolumab
1
Metformin
1
Ipilimumab
1
Granulocyte Colony-Stimulating Factor
1
Gefitinib
1
Filgrastim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma of Lung
×
binimetinib
×
30 days
×
Clear all
No trials found.